Sidhu

Sidhu v. Bayer Healthcare Pharmaceuticals Inc.

Good Law
United States District Court, Northern District of CaliforniaNovember 22, 20225:22-cv-01603California8,561 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION 6 PRIYA SIDHU, Case No. 22-cv-01603-BLF

Plaintiff,

ORDER GRANTING IN PART AND

v. DENYING IN PART MOTION TO

DISMISS WITH LEAVE TO AMEND

BAYER HEALTHCARE IN PART AND WITHOUT LEAVE TO

PHARMACEUTICALS INC., AMEND IN PART

11 Defendant. 12 In this case, Plaintiff Priya Sidhu alleges that Defendant Bayer Healthcare Pharmaceuticals Inc. (“Bayer”) markets and sells an IUD that significantly increases the risk of breast cancer in users. She brings common law and state statutory claims, and she seeks to represent both a California and a nationwide class. Now before the Court is Bayer’s motion to dismiss under Rules 12(b)(1) and 12(b)(6). ECF No. 17 (“MTD”); see also ECF No. 25 (“Reply”). Sidhu opposes the motion. ECF No. 22 (“Opp.”). The Court held a hearing on October 27, 2022. For the reasons discussed on the record and explained below, the Court GRANTS IN PART and…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.